No records
|
494 |
8603606800 |
Suko Adiarto |
dr. Suko Adiarto, Sp.JP., PhD |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Successful Primary PCI in Stanford Type A Aortic Dissection Complicated by Inferior ST-Elevation Myocardial Infarction: A Case in a Facility with No Surgical Backup |
Adiarto S., Kurnianingsih N., Prasetya I., Nugroho F.W., Uberoi R. |
International Journal of Angiology |
|
Q3 |
|
|
495 |
8603606800 |
Suko Adiarto |
dr. Suko Adiarto, Sp.JP., PhD |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient |
Nugraha R.A., Muliawan H.S., Nugroho N.T., Ikhsan M., Adiarto S. |
International Journal of Angiology |
|
Q3 |
|
|
504 |
8603606800 |
Suko Adiarto |
dr. Suko Adiarto, Sp.JP., PhD |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Successful Ovarian Vein Embolization of a Multiparous Woman with Pelvic Congestion Syndrome |
Setiani R.U., Batubara E.A.D., Adiarto S., Siddiq T., Indriani S., Siahaan I.H. |
International Journal of Angiology |
|
Q3 |
|
|
No records
|
138 |
8651025300 |
Renan Sukmawan |
dr. Renan Sukmawan, S.T., Sp.JP., Ph.D. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
The effect of external counterpulsation on intrinsic myocardial function evaluated by speckle tracking echocardiography in refractory angina patients: a randomized controlled trial |
Pravian D., Soesanto A.M., Ambari A.M., Kuncoro B.R.M.A.S., Dwiputra B., Muliawan H.S., Sukmawan R. |
International Journal of Cardiovascular Imaging |
1 |
Q2 |
|
|
342 |
8651025300 |
Renan Sukmawan |
dr. Renan Sukmawan, S.T., Sp.JP., Ph.D. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI) |
Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I. |
Pharmacology Research and Perspectives |
|
Q1 |
|
|
530 |
8651025300 |
Renan Sukmawan |
dr. Renan Sukmawan, S.T., Sp.JP., Ph.D. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Diagnostic prediction model in subjects with low-risk unstable angina pectoris/Non-ST Segment Elevation Myocardial Infarction |
Dakota I., Munawar M., Pranata R., Raffaello W.M., Sukmawan R. |
European Review for Medical and Pharmacological Sciences |
|
Q2 |
|
|
587 |
8651025300 |
Renan Sukmawan |
dr. Renan Sukmawan, S.T., Sp.JP., Ph.D. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study |
Giantini A., Timan I.S., Listiyaningsih E., Dharma R., Setiabudy R., Alwi I., Partakusuma L.G., Indrasari N.D., Harahap? A.R., Suparmin? S., Sahar W., Sukmawan R. |
Indonesian Biomedical Journal |
|
Q4 |
|
|
No records
|
12 |
8661764000 |
Lugyanti Sukrisman |
Dr. dr. Lugyanti Sukrisman, Sp.P.D(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Soluble P-selectin and correlation with Prothrombin Fragment?1 + 2 in myeloid malignancies in Cipto Mangunkusumo general hospital |
Sukrisman L. |
Thrombosis Journal |
|
Q2 |
|
|
236 |
8661764000 |
Lugyanti Sukrisman |
Dr. dr. Lugyanti Sukrisman, Sp.P.D(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Comparison between PRP and PRFM on FTSG healing profile: Macroscopic, microscopic and ELISA evaluation |
Reksodiputro M.H., Harahap A.R., Siregar N.C., Malik S.G., Bashirudin J., Boesoirie M.T.S., Widodo D.W., Iljanto S., Sajuthi D., Sukrisman L., Yosia M. |
Annals of Medicine and Surgery |
|
Q3 |
|
|